| Title : Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: propensity score analysis of a territory-wide cohort in Hong Kong - Wong_2021_Diabetes.Metab__101307 |
| Author(s) : Wong CKH , Lui DTW , Lui AYC , Kwok ACY , Low MCH , Lau KTK , Au ICH , Xiong X , Chung MSH , Lau EHY , Cowling BJ |
| Ref : Diabetes Metab , :101307 , 2021 |
| Abstract : Wong_2021_Diabetes.Metab__101307 |
| ESTHER : Wong_2021_Diabetes.Metab__101307 |
| PubMedSearch : Wong_2021_Diabetes.Metab__101307 |
| PubMedID: 34863934 |
Wong CKH, Lui DTW, Lui AYC, Kwok ACY, Low MCH, Lau KTK, Au ICH, Xiong X, Chung MSH, Lau EHY, Cowling BJ (2021)
Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: propensity score analysis of a territory-wide cohort in Hong Kong
Diabetes Metab
:101307
Wong CKH, Lui DTW, Lui AYC, Kwok ACY, Low MCH, Lau KTK, Au ICH, Xiong X, Chung MSH, Lau EHY, Cowling BJ (2021)
Diabetes Metab
:101307